Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Kateryna Krytska | Researchclopedia

Back to researchers

Kateryna Krytska

Children's Hospital of Philadelphia

164

Works

1,830

Citations

18

h-index

22

i10-index

Research Topics

Neuroblastoma Research and Treatments Cancer, Hypoxia, and Metabolism Cancer therapeutics and mechanisms

Affiliations

Children's Hospital of Philadelphia2013–2025

Thomas Jefferson University2012–2012

Virginia Commonwealth University2023–2023

Uzhhorod National University2007–2008

University of Pennsylvania2007–2021

Top Works

ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma

Scott C. Bresler,Daniel A. Weiser,et al.

2014386 citations

Lung Cancer Research Studies

Neuroendocrine Tumor Research Advances

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma

Nicole R. Infarinato,Jin H. Park,et al.

2015180 citations

Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

Jo Lynne Rokita,Komal S. Rathi,et al.

2019163 citations

Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

Jungoh Ham,Carlotta Costa,et al.

2016130 citations

The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

Nathan M. Kendsersky,Jarrett M. Lindsay,et al.

2021118 citations

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

Kelly C. Goldsmith,Julie R. Park,et al.

2023117 citations

Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma

Kateryna Krytska,Hannah T. Ryles,et al.

2015105 citations

Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma

Andrew Wood,Kateryna Krytska,et al.

201696 citations

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models

Caitlin D. Lowery,Michele Dowless,et al.

201879 citations